Repair. Regenerate. Restore.
The importance of collagen is well understood within the medical industry. Collagen-based regenerative matrices have been widely used in applications such as drug and other biologics delivery and wound healing. However, for soft tissue repair, the historical challenge of collagen-based implants has been creating a graft with sufficient biological and mechanical performance. Embody is leveraging our creative chemistries and improving upon two separate advanced additive manufacturing platforms, electrospinning and microfluidic extrusion, to address these prior limitations.
Microfibrous collagen bioengineered implant for soft tissue augmentation with biomechanical performance
Microfluidic biofabrication to precisely control molecular assembly of collagen microfibers
TAPESTRY Biointegrative Implant is the first collagen-based implant with a bioengineered micro-architecture and bio-stimulative, highly organized Type I collagen chemistry specifically designed for tendon repair. TAPESTRY’s proprietary physio-chemistry demonstrated dense collagenous tissue in-growth.
TAPESTRY RCR* incorporates the TAPESTRY Biointegrative Implant with a novel delivery and fixation system for the augmentation of partial to full tear rotator cuff repairs via 510(k) pathway in 2021.
MICROBRAID* high-strength, collagen orthopedic suture line capitalizing on the strength and remodeling enabled by our FABRITEC technology.
MICROBRACE* leverages a collagen orthopedic suture with a full implant and instrument solution for extra-articular applications.
* This product is not cleared by the USFDA for commercial distribution of sale in the United States.